Bicara Therapeutics

race track
Biotech

Bicara CEO: ASCO data resonate more with 'people that matter'

"Our data is resonating far more with the people that matter, which are the head and neck oncologists," Bicara's CEO told Fierce.
Gabrielle Masson Jun 2, 2025 4:26pm
Blue race track

ASCO: Chasing Merus, Bicara shares 2-year HNSCC survival data

Jun 1, 2025 3:36pm
Flexibility and adaptation concept Arrows on cubes following a flexible path

'One of the lucky few': Bicara CEO on last year's $326M IPO

Apr 14, 2025 3:59pm
Court lawsuit legal litigation

Biocon accused of IP theft to create cancer biotech Bicara

Oct 24, 2024 11:04am
Graphic image of the letters IPO in white in front of a yellow background

Zenas, MBX, Bicara head to Nasdaq in hot day for biotech IPOs

Sep 13, 2024 5:25am
IPO initial public offering Wall Street

Zenas, Bicara set out to raise $180M-plus in separate IPOs

Sep 6, 2024 8:18am